Condition: EBV Infection · Sponsor: Labo'Life
Worldwide, 95% of adults are infected with Epstein-Barr Virus (EBV). These infections may cause different diseases. In most cases, EBV infection is asymptomatic because of a highly effective host immune response. Some individuals develop infectious mononucleosis (a self-limiting lymphoproliferative disorder in adolescents and young adults that is considered to be the primary infection), while others develop chronic fatigue syndrome, EBV-associated lymphoid, or epithelial malignancies. Today, there is no available treatment to treat and destroy EBV. The treatment is essentially symptomatic (treatment of the symptoms and not of the virus itself) with analgesics for pain for example. The studied drugs are 2LEBV® and 2LXFS®, from Labo'Life company, and the treatment schema is the same for the two drugs: it consists in taking the content of one capsule per day, sequentially, according to capsules' numerical order: 1 through 10. When capsule number 10 is taken, capsule 1 of the next blister should be taken on the next day to continue the treatment. The duration of treatment will be of 6 months of continuous intake of the content of 1 capsule/day. The aim of this study is to provide additional information on effectiveness on the 2LEBV® and 2LXFS®in the treatment of EBV chronic and acute infections, and in particular to demonstrate their effectiveness versus placebo in the reduction of asthenia and other symptoms in EBV infection.
This description comes directly from the study's public registry record.
Charlotte BOLLE · 497 49 13 74 · charlotte.bolle@labolife.com
Laura FERTE · 499 71 79 64 · laura.ferte@labolife.com
Always discuss trial participation with your own doctor first.
| Private Practice | Aartselaar, Belgium | Recruiting |
| Private Practice | Boortmeerbeek, Belgium | Terminated |
| Private Practice | Brussels, Belgium | Recruiting |
| Private practice | Brussels, Belgium | Recruiting |
| Private Practice | Brussels, Belgium | Recruiting |
| Private Practice | Ghent, Belgium | Recruiting |
| Private Practice | Jette, Belgium | Withdrawn |
| Private Practice | Limal, Belgium | Withdrawn |
| Private practice | Marche-en-Famenne, Belgium | Recruiting |
| Cabinet privé | Schoten, Belgium | Recruiting |
| Private practice | Stavelot, Belgium | Recruiting |
| Private practice | Waregem, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04308278